GSK vaccines storage and rotation contract
Active Awarded Last action
- Contract number
- 75D30123F00001
- Awardee
-
Glaxosmithkline, LLC UEI FRHTPHMZMX47
- Awarding agency
-
CDC Pittsburgh
Centers for Disease Control and Prevention, Department of Health and Human Services
- Obligated
- $1,566,691
Award facts
- Opportunity
-
- 75D30123R72735 Solicitation number
- Contract value 58% obligated
-
- $2,080,435.40 Current, with exercised options
- $2,686,954.32 Potential, with all options
- Completion date 64% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- R799 Support- Management: Other
- Set-aside
- No set-aside
- Competition
- Not Competed Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Durham, NC 27701, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $515,978 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $531,711 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $519,001 |
Show all 14
About this award
The Centers for Disease Control and Prevention Pittsburgh issued a delivery order to Glaxosmithkline, LLC on August 15, 2023, with a ceiling value of $2,686,954.32 for GSK vaccine storage and rotation services, including administrative modification for borrowing and returning of stockpile vaccine doses.
Place of performance is Durham, NC 27701. The order is firm fixed price with an ultimate completion date of August 14, 2028. No set-aside was used. Glaxosmithkline is a foreign-owned pharmaceutical manufacturer that operates exclusively as a prime contractor with no subcontract footprint, competing full-and-open across a broad federal portfolio anchored by large vaccine supply agreements with the CDC and Department of Health and Human Services.
Quick answers
Who was awarded contract 75D30123F00001?
75D30123F00001 was awarded to Glaxosmithkline, LLC by CDC Pittsburgh (Centers for Disease Control and Prevention) on August 15, 2023.
How much is contract 75D30123F00001 worth?
The government has obligated $1,566,691 on 75D30123F00001. Its current value, with exercised options, is $2,080,435. Its potential value, with all options, is $2,686,954.
Is contract 75D30123F00001 an order under another contract?
Yes. 75D30123F00001 is a delivery order under 75D30123D16461, an indefinite delivery contract.
Was contract 75D30123F00001 competed?
The extent of competition for 75D30123F00001 was not competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award